These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31895253)

  • 21. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
    Bush R; Bush P
    Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleomycin Electrosclerotherapy Treatment in the Management of Vascular Malformations.
    Kostusiak M; Murugan S; Muir T
    Dermatol Surg; 2022 Jan; 48(1):67-71. PubMed ID: 34608081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of foam sclerotherapy for the treatment of oropharyngeal venous malformation].
    Niu CQ; Jiang H; Zhou SY; Shen G; Li HB; Zhang J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Mar; 53(3):209-213. PubMed ID: 29614554
    [No Abstract]   [Full Text] [Related]  

  • 24. An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
    Peterson JD; Goldman MP
    Dermatol Surg; 2011 Jan; 37(1):12-7. PubMed ID: 21199095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful Sclerotherapy for Cervicofacial Macrocystic Lymphatic Malformations Using Polidocanol and Pingyangmycin Combined Foam Sclerosants.
    Wang Q; Zhou Q; Zhao Z; Liu C; Zheng J
    Lymphat Res Biol; 2022 Oct; 20(5):507-513. PubMed ID: 35041550
    [No Abstract]   [Full Text] [Related]  

  • 26. [Controlled sclerosing in the treatment of venous maxillofacial malformations].
    Grishin AA; Durdyev OS; Smyslenova MV; Drobyshev AY
    Stomatologiia (Mosk); 2019; 98(4):60-64. PubMed ID: 31513152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
    Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
    Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
    Tessari L; Cavezzi A; Frullini A
    Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.
    Horbach SE; Lokhorst MM; Saeed P; de Goüyon Matignon de Pontouraude CM; Rothová A; van der Horst CM
    J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):295-304. PubMed ID: 26723834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.
    Blaise S; Charavin-Cocuzza M; Riom H; Brix M; Seinturier C; Diamand JM; Gachet G; Carpentier PH
    Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):412-7. PubMed ID: 21111641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
    Ukritmanoroat T
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Saphenous ablation: sclerosant or sclerofoam?
    Coleridge Smith P
    Semin Vasc Surg; 2005 Mar; 18(1):19-24. PubMed ID: 15791549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany.
    Breu FX; Guggenbichler S
    Dermatol Surg; 2004 May; 30(5):709-17; discussion 717. PubMed ID: 15099312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a single-center experience.
    Grieb D; Meila D; Greling B; Jacobs C; Hechtner M; Schlunz-Hendann M; Brassel F
    Acta Radiol; 2019 May; 60(5):593-601. PubMed ID: 30111191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and Safety of Sclerotherapy for Treatment of Low-Flow Vascular Malformations of the Oropharyngeal Region.
    Bourgouin P; Thomas-Chaussé F; Gilbert P; Giroux MF; Périgny S; Guertin L; Dubois J; Soulez G
    J Vasc Interv Radiol; 2018 Jun; 29(6):809-815. PubMed ID: 29628299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
    Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
    Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerotherapy with Adjunctive Stasis of Efflux (STASE) in Venous Malformations: Techniques and Strategies.
    Legiehn GM
    Tech Vasc Interv Radiol; 2019 Dec; 22(4):100630. PubMed ID: 31864535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of sclerosant foams by mechanical methods increases the foam temperature.
    Tan L; Wong K; Connor D; Fakhim B; Behnia M; Parsi K
    Phlebology; 2017 Aug; 32(7):501-505. PubMed ID: 27738239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.